Many People Are Overdosing on Ozempic Alternatives with DIY Injections, FDA Warns

Mar. 15, 2025

Photo:Getty

Getty

Many people are finding themselves overdosing on alternatives to Ozempic and Wegovy due to the do-it-yourself doses of compounded semaglutide.

Becky Cheairs, 66, toldThe New York Timesthat she was prescribed an Ozempic alternative through a telehealth service. Unlike Ozempic, which comes in injectables that are pre-filled with a specific dose, Cheairs was given a vial of the medication and a bag of syringes for her to draw the drug out herself with written instructions.

She accidentally injected herself with five times the amount she was supposed to take, telling the outlet that getting the dose wrong is “such an easy mistake to make, especially for a lay person.”

Ricardo Rubio/Europa Press via Getty

Never miss a story — sign up forPEOPLE’s free daily newsletterto stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.

A few hours after taking the medication, Cheairs began vomiting and she spent the following day throwing up at least once an hour.

The U.S. Food and Drug Administration states that these accidents areincreasingly common. In some instances, patients reportedly administered five to 20 times more than the intended dose of semaglutide. The agency notes that they do not review, test or approve these compounded drugs for safety.

Additionally, there have reportedly been 159 calls to national poison control centers so far this year involving compounded GLP-1s, the class of medications that includes semaglutide, according to theTimes.

“FDA encourages patients to talk with their health care provider or compounder about how to measure and administer the intended dose of compounded semaglutide,”officials wrote.

In December 2023, theFDAissued a warning about the knockoff products that have infiltrated the “legitimate U.S. drug supply chain.”

“The agency advises wholesalers, retail pharmacies, health care practitioners and patients to check the product they have received and not distribute, use, or sell products labeled with lot number NAR0074 and serial number 430834149057,” the alert said. “Some counterfeit products may still be available for purchase.”

The warning came after numerous people werehospitalizeddue to adverse effects of taking the counterfeit products.

In a statement on its website, Novo Nordisk said, “Falsified or counterfeit products represent a true public health risk today. The effect or lack of effect in the body can be very damaging to the people exposed. So to protect the health and safety of patients worldwide we are actively engaged in efforts to combat counterfeiting.”

If you suspect you have a counterfeit product, the FDA urges you to submit a report online atMedWatch Online Voluntary Reporting Form— or you can reach out to Novo Nordisk via thiscontact form.

source: people.com